AI-generated summary
The authors studied HeLa cervical cancer cells and CHO normal cells treated in vitro with sinensetin, a natural polyphenol, and low-level laser therapy at 660 nm, alone or combined. They report that laser pretreated before sinensetin reduced viability of both cell lines more than the reverse order, and that combined treatment increased cell death and reactive oxygen species production. The study used cell cultures only, not patients or animals.
- Who or what was studied
- HeLa (cervical cancer) and CHO (normal) cell lines cultured in vitro
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study used cultured cells only, with no animal or human data, and the abstract does not report sample sizes or a total number of participants.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 3 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Reactive oxygen species, Statistical significance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.